Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue7¢$123.9K
- Research and development93¢$1.8M
Out of $1.7M in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | $04 | $03 | $1.7M3 | ||
| Cost of revenue | $03 | $123.9K3 | |||
| Gross profit | $03 | $1.6M3 | |||
| Research and development | $206.4K5 | $348.8K4 | $159.8K3 | $1.8M3 | |
| Operating expenses | $5.0M3 | $5.0M3 | |||
| Operating income | -$548.7K5 | -$709.9K4 | -$5.0M3 | -$3.5M3 | |
| Interest | $367.1K3 | $03 | |||
| Income before tax | -$8.3M3 | -$3.5M3 | |||
| Income tax | $04 | $03 | $03 | ||
| Net income | -$548.7K5 | -$732.2K4 | -$9.1M3 | -$3.0M3 | |
| Earnings per share | -$0.313 | -$0.043 | |||
| Earnings per share (diluted) | -$0.313 | -$0.043 | |||
| Shares (weighted, basic) | 29.4M shares3 | 68.1M shares3 | |||
| Shares (weighted, diluted) | 29.4M shares3 | 68.1M shares3 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Cash | $04 | $129.0K4 | $7.1K3 | $97.6K3 | |
| Receivables | $03 | $1.2M3 | |||
| Inventory | $03 | $403.6K3 | |||
| Current assets | $105.8K5 | $139.0K4 | $313.1K3 | $2.5M3 | |
| Property, plant and equipment | $03 | $83.3K3 | |||
| Intangible assets | $03 | $95.4K3 | |||
| Total assets | $170.6K5 | $164.9K4 | $423.1K3 | $2.8M3 | |
| Current liabilities | $36.4K5 | $84.0K4 | $1.1M3 | $5.8M3 | |
| Long-term liabilities | $04 | ||||
| Total liabilities | $36.4K5 | $727.5K4 | $1.1M3 | $5.8M3 | |
| Retained earnings | -$10.5M3 | -$13.7M3 | |||
| Shareholders’ equity | $308.8K5 | $134.2K4 | -$562.6K4 | -$647.6K3 | -$2.8M3 |
| Shares outstanding | 9.7M shares5 | 9.7M shares4 | 67.0M shares3 | 72.2M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What Healthtech Solutions, Inc./UT reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Area of land | 10,800 sq ft3 Sep 26, 2022 |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $97.6K3 Dec 31, 2022 | $7.1K3 Dec 31, 2021 | +1273.5% |
Intangibles and goodwill
Inventory
Leadership
Who has led Healthtech Solutions, Inc./UT, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief operating officer
- Chief executive officerEdward Winslow Swanson Jul 16, 2021 to Jul 16, 20218
- Chief executive officerRobert Brantl Jun 5, 2020 to Sep 11, 20209
- ChairLing Tian Apr 5, 2006 to Apr 5, 200610
- Chief operating officerBradley K. Mathis Jul 14, 2021 to Jul 14, 202111
Board members and other officers (3)
- Board memberPaul Elliot Mann Jul 16, 2021 to Nov 30, 202212
- Board memberRyan M. Salomone Jul 20, 2021 to Jul 20, 202113
- Board memberRobert Brantl Jun 5, 2020 to Sep 11, 20209
Former names
Timeline
- Jun 13, 20258-K Entered a material agreement; Completed an acquisition or sale; Executive or director change14
- Feb 21, 20258-K Executive or director change; Shareholder vote15
- Jan 10, 20258-K Executive or director change16
- Sep 6, 20238-K Entered a material agreement17
- Jul 28, 20238-K Other events18
- Mar 23, 20238-K Executive or director change19
- Feb 2, 20238-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares20
- Jan 6, 20238-K Regulation FD disclosure21
- Dec 22, 20228-K Entered a material agreement22
- Sep 12, 20228-K Unregistered sale of shares23
- Feb 3, 20228-K Completed an acquisition or sale24
- Jan 21, 20228-K Entered a material agreement25
- Jul 16, 2021New chief executive Edward Winslow Swanson becomes CEO8
- Jun 5, 2020New chief executive Robert Brantl becomes CEO9
Filings
35 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 16 major events, 2 insider forms, 11 other. The latest 20:
- Nov 25, 2025REVOKED EDGAR
- Jun 13, 20258-K EDGAR
- Feb 21, 20258-K EDGAR
- Jan 27, 2025DEF 14C EDGAR
- Jan 10, 20258-K EDGAR
- Dec 20, 2024PRE 14C EDGAR
- Sep 6, 20238-K EDGAR
- Jul 28, 20238-K EDGAR
- Jun 28, 202310-K EDGAR
- Mar 31, 2023NT 10-K EDGAR
- Mar 23, 20238-K EDGAR
- Feb 2, 20238-K EDGAR
- Jan 6, 20238-K EDGAR
- Dec 22, 20228-K EDGAR
- Nov 30, 20224/A PRIMARY DOCUMENT EDGAR
- Nov 30, 20224 PRIMARY DOCUMENT EDGAR
- Nov 23, 202210-Q EDGAR
- Nov 14, 2022NT 10-Q EDGAR
- Sep 12, 20228-K EDGAR
- Aug 31, 2022SEC STAFF ACTION EDGAR
The 35 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Healthtech Solutions, Inc./UT is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARHealthtech Solutions, Inc./UT1
- CIK0001307624
- Employer ID (EIN)84-25286601
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inUtah1
- Fiscal year endsDecember 311
- Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address615 S. Arapeen Drive, Suite 300, Salt Lake City, UT 841081
- Phone844-926-33991
- Shares outstanding96,131,606 as of Jun 26, 20233
- Public float$7.0M as of Jun 30, 20223
- On EDGAR sinceNov 5, 20041
- Filings168 in all: 8-K (46), 10-Q (19), 3 (11), 10QSB (10), NT 10-Q (10), UPLOAD (9), 10-K (7), CORRESP (7)1
All 32 form types
NT 10-K (6), PRE 14C (5), 10KSB (4), 10-K/A (3), 10-Q/A (3), 4 (3), DEF 14C (3), 10-12G/A (2), 10SB12G/A (2), D (2), S-8 (2), S-8 POS (2), 1-A (1), 10-12G (1), 10QSB/A (1), 10SB12G (1), 15-12G (1), 4/A (1), 8-K/A (1), REVOKED (1), SC 13D (1), SC 13D/A (1), SC 14F1 (1), SEC STAFF ACTION (1)
- Latest filingsAnnual report (10-K) Jun 28, 2023
Quarterly report (10-Q) Nov 23, 2022
Latest 8-K (8-K) Jun 13, 2025
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARLing Tian, Chair
- 11
- 12SEC EDGARPaul Elliot Mann, Board member
- 13SEC EDGARRyan M. Salomone, Board member
- 14
- 15
- 16SEC EDGARExecutive or director change
- 17SEC EDGAREntered a material agreement
- 18SEC EDGAROther events
- 19SEC EDGARExecutive or director change
- 20
- 21SEC EDGARRegulation FD disclosure
- 22SEC EDGAREntered a material agreement
- 23SEC EDGARUnregistered sale of shares
- 24SEC EDGARCompleted an acquisition or sale
- 25SEC EDGAREntered a material agreement